CareDx, Inc. (CDNA) is a publicly traded Healthcare sector company. As of July 16, 2026, CDNA trades at $37.10 with a market cap of $1.49B and a P/E ratio of -185.19. CDNA moved +24.64% today. Year to date, CDNA is +57.91%; over the trailing twelve months it is +56.50%. Its 52-week range spans $10.96 to $30.00. Analyst consensus is buy with an average price target of $28.00. Rallies surfaces CDNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover CDNA: 0 strong buy, 2 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $28.00.
| Metric | Value |
|---|---|
| Price | $37.10 |
| Market Cap | $1.49B |
| P/E Ratio | -185.19 |
| EPS | $-0.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.00 |
| 52-Week Low | $10.96 |
| Volume | 1.59M |
| Avg Volume | 0 |
| Revenue (TTM) | $412.82M |
| Net Income | $-8.19M |
| Gross Margin | 0.00% |
5 analysts cover CDNA: 0 strong buy, 2 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $28.00.